BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30124809)

  • 1. Balancing sufficiency and impact in reporting standards for mass spectrometry imaging experiments.
    Gustafsson OJR; Winderbaum LJ; Condina MR; Boughton BA; Hamilton BR; Undheim EAB; Becker M; Hoffmann P
    Gigascience; 2018 Oct; 7(10):. PubMed ID: 30124809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMART: A data reporting standard for mass spectrometry imaging.
    Xi Y; Sohn AL; Joignant AN; Cologna SM; Prentice BM; Muddiman DC
    J Mass Spectrom; 2023 Feb; 58(2):e4904. PubMed ID: 36740651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative mass spectrometry imaging of amino acids with isomer differentiation in brain tissue via exhaustive liquid microjunction surface sampling-tandem mass tags labeling-ultra performance liquid chromatography-mass spectrometry.
    Wu Q; Li Y; Wang Y; Lu H
    J Chromatogr A; 2020 Jun; 1621():461086. PubMed ID: 32327225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for reporting quantitative mass spectrometry based experiments in proteomics.
    Martínez-Bartolomé S; Deutsch EW; Binz PA; Jones AR; Eisenacher M; Mayer G; Campos A; Canals F; Bech-Serra JJ; Carrascal M; Gay M; Paradela A; Navajas R; Marcilla M; Hernáez ML; Gutiérrez-Blázquez MD; Velarde LF; Aloria K; Beaskoetxea J; Medina-Aunon JA; Albar JP
    J Proteomics; 2013 Dec; 95():84-8. PubMed ID: 23500130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mass spectrometry imaging technology and its application in breast cancer research].
    Zhang M; Zhang Y; Wang H; Li N; Li B; Xiao H; Bian W; Cai Z
    Se Pu; 2021 Jun; 39(6):578-587. PubMed ID: 34227318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality will determine the future of mass spectrometry imaging in clinical laboratories: the need for standardization.
    Ucal Y; Coskun A; Ozpinar A
    Expert Rev Proteomics; 2019 Jun; 16(6):521-532. PubMed ID: 31122141
    [No Abstract]   [Full Text] [Related]  

  • 10. The minimum information required for a glycomics experiment (MIRAGE) project: improving the standards for reporting mass-spectrometry-based glycoanalytic data.
    Kolarich D; Rapp E; Struwe WB; Haslam SM; Zaia J; McBride R; Agravat S; Campbell MP; Kato M; Ranzinger R; Kettner C; York WS
    Mol Cell Proteomics; 2013 Apr; 12(4):991-5. PubMed ID: 23378518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging mass spectrometry statistical analysis.
    Jones EA; Deininger SO; Hogendoorn PCW; Deelder AM; McDonnell LA
    J Proteomics; 2012 Aug; 75(16):4962-4989. PubMed ID: 22743164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI).
    Sumner LW; Amberg A; Barrett D; Beale MH; Beger R; Daykin CA; Fan TW; Fiehn O; Goodacre R; Griffin JL; Hankemeier T; Hardy N; Harnly J; Higashi R; Kopka J; Lane AN; Lindon JC; Marriott P; Nicholls AW; Reily MD; Thaden JJ; Viant MR
    Metabolomics; 2007 Sep; 3(3):211-221. PubMed ID: 24039616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [
    Lopci E; Hicks RJ; Dimitrakopoulou-Strauss A; Dercle L; Iravani A; Seban RD; Sachpekidis C; Humbert O; Gheysens O; Glaudemans AWJM; Weber W; Wahl RL; Scott AM; Pandit-Taskar N; Aide N
    Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2323-2341. PubMed ID: 35376991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BASTet: Shareable and Reproducible Analysis and Visualization of Mass Spectrometry Imaging Data via OpenMSI.
    Rubel O; Bowen BP
    IEEE Trans Vis Comput Graph; 2018 Jan; 24(1):1025-1035. PubMed ID: 28866551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIRAGE: the minimum information required for a glycomics experiment.
    York WS; Agravat S; Aoki-Kinoshita KF; McBride R; Campbell MP; Costello CE; Dell A; Feizi T; Haslam SM; Karlsson N; Khoo KH; Kolarich D; Liu Y; Novotny M; Packer NH; Paulson JC; Rapp E; Ranzinger R; Rudd PM; Smith DF; Struwe WB; Tiemeyer M; Wells L; Zaia J; Kettner C
    Glycobiology; 2014 May; 24(5):402-6. PubMed ID: 24653214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative aspects of inductively coupled plasma mass spectrometry.
    Bulska E; Wagner B
    Philos Trans A Math Phys Eng Sci; 2016 Oct; 374(2079):. PubMed ID: 27644971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of mass spectrometry imaging in virus research.
    Bertzbach LD; Kaufer BB; Karger A
    Adv Virus Res; 2021; 109():31-62. PubMed ID: 33934829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future technology insight: mass spectrometry imaging as a tool in drug research and development.
    Cobice DF; Goodwin RJ; Andren PE; Nilsson A; Mackay CL; Andrew R
    Br J Pharmacol; 2015 Jul; 172(13):3266-83. PubMed ID: 25766375
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.